secwatch.observer — SEC 8-K summary
======================================

Issuer:     GT Biopharma, Inc. (GTBP)
CIK:        0000109657
Form:       8-K
Filed at:   2022-06-10T23:59:59+00:00
Accession:  0001493152-22-016394
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

GT Biopharma appoints Alan L. Urban to Board and Audit Committee
----------------------------------------------------------------

- Alan L. Urban appointed to fill vacant Board seat and serve on Audit Committee effective June 9, 2022.
- Board determined Urban qualifies as independent director under Nasdaq rules.
- Urban has 25+ years finance/accounting experience, including CFO at Research Solutions (RSSS) and ReachLocal (RLOC).
- Urban is a CPA (inactive) since 1998; holds B.S. in Accounting from California State University, Northridge.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/109657/000149315222016394/0001493152-22-016394-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/109657/000149315222016394/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-016394

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer